“Global Transplant market set to grow to $45bn by 2024” says new Visiongain report

18 December 2018
Pharma

Visiongain has launched a new pharma report Global Transplant Market Report : Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users.

The worldwide rise in the demand for tissue or organs for transplant can be attributed to upsurge in the incidence of acute or chronic diseases. For instance, high blood pressure and diabetes are the foremost causes of end-stage kidney conditions, where kidney transplantation or dialysis is the solitary treatment possibilities to save a patient’s life. As stated by the National Kidney Foundation, there were approximately 122,737 patients in the U.S., who are waiting to receive organs for transplantation in 2014. Thus, there is growing demand for high-end tissue products for the treatment of organ damage or failure, and leukaemia treatment.

The lead analyst of the report commented "Rising number of transplant surgeries, escalating prevalence of chronic diseases, and developing healthcare infrastructure in emerging economies such as China, India, South Africa, Brazil, Mexico, and Indonesia are factors that will drive the demand for transplant products. However, factors such as lack of skilled professionals and high cost of organ transplant surgeries are expected to limit the market growth."

Leading companies featured in the report include AbbVie, Inc., Arthrex, Inc., Medtronic, Novartis AG, Stryker, Teva Pharmaceuticals, Veloxis Pharmaceuticals, Zimmer Biomet

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

Read

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

Read

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

Read

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever